IXC 2.30% 8.5¢ invex therapeutics ltd

From my perspective, over the short-term (3 - 6 months), I don't...

  1. 282 Posts.
    lightbulb Created with Sketch. 81
    From my perspective, over the short-term (3 - 6 months), I don't see the share price going over 70 cents given the poor macro picture with veritable market fragility. Until release of phase 3 results (Q1 CY2025), the share price will likely be constrained unless: a) market awareness of IXC significantly improves or b) new conditions are identified and pursued that materially increases TAM or c) phase 3 trial is completed earlier than expected (which is a possibility given the strong community demand for a therapeutic - meaning easily identifiable pool of patients) or d) a significant investor seeks to enter the share registry.

    I'm happy to play the waiting game and of course grateful that financially I can afford to do so
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
8.5¢
Change
-0.002(2.30%)
Mkt cap ! $6.388M
Open High Low Value Volume
8.4¢ 8.5¢ 8.4¢ $2.955K 35K

Buyers (Bids)

No. Vol. Price($)
1 94523 8.5¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 58500 1
View Market Depth
Last trade - 12.29pm 28/03/2024 (20 minute delay) ?
Last
8.5¢
  Change
-0.002 ( 1.19 %)
Open High Low Volume
8.5¢ 8.5¢ 8.5¢ 5000
Last updated 12.46pm 28/03/2024 ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.